Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (8): 467-471.doi: 10.3760/cma.j.cn371439-20190712-00059
• Original Articles • Previous Articles Next Articles
Received:
2019-07-12
Revised:
2020-01-10
Online:
2020-08-08
Published:
2020-10-22
Contact:
Liu Lianke
E-mail:liulianke@jsph.org.cn
Wang Tingting, Liu Lianke. Predictive values of preoperative LMR and PLR in early postoperative recurrence of patients with esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2020, 47(8): 467-471.
"
临床病理特征 | 复发组 (n=41) | 对照组 (n=42) | t/χ2/Z值 | P值 |
---|---|---|---|---|
年龄(岁,$\bar{x}±s$) | 62.0±7.2 | 62.8±5.9 | 0.560 | 0.577 |
性别[例(%)] | ||||
男 | 38(92.7) | 35(83.3) | 1.711 | 0.191 |
女 | 3(7.3) | 7(16.7) | ||
LMR($\bar{x}±s$) | 3.91±1.73 | 5.08±2.15 | 2.710 | 0.008 |
PLR($\bar{x}±s$) | 142.81±67.80 | 114.03±42.47 | 2.324 | 0.023 |
分化程度 [例(%)] | ||||
Ⅰ级 | 1(2.4) | 2(4.8) | 0.321 | 0.571 |
Ⅱ~Ⅲ级 | 40(97.6) | 40(95.2) | ||
肿瘤直径 (cm,$\bar{x}±s$) | 4.28±1.61 | 3.19±1.30 | 3.420 | 0.001 |
浸润深度 [例(%)] | ||||
T1 | 4(9.8) | 11(26.2) | ||
T2 | 8(19.5) | 13(30.9) | 2.633 | 0.008 |
T3 | 29(70.7) | 18(42.9) | ||
T4 | 0(0) | 0(0) | ||
淋巴结转移 [例(%)] | ||||
有 | 34(82.9) | 27(64.3) | 3.701 | 0.054 |
无 | 7(17.1) | 15(35.7) | ||
临床分期 [例(%)] | ||||
Ⅰ期 | 0(0) | 5(11.9) | ||
Ⅱ期 | 10(24.3) | 15(35.7) | 2.616 | 0.009 |
Ⅲ期 | 27(65.9) | 21(50.0) | ||
ⅣA期 | 4(9.8) | 1(2.4) | ||
术后治疗 [例(%)] | ||||
是 | 40(97.6) | 37(88.1) | 2.772 | 0.096 |
否 | 1(2.4) | 5(11.9) |
[1] |
Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil[J]. J Clin Invest, 2015,125(9):3347-3355. DOI: 10.1172/JCI80007.
pmid: 26325032 |
[2] |
Gu L, Li H, Chen L, et al. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis[J]. Oncotarget, 2016,7(22):31926-31942. DOI: 10.18632/oncotarget.7876.
doi: 10.18632/oncotarget.7876 pmid: 26942464 |
[3] |
Li Z, Xu Z, Huang Y, et al. Prognostic values of preoperative platelet-to-lymphocyte ratio, albumin and hemoglobin in patients with non-metastatic colon cancer[J]. Cancer Manag Res, 2019,11:3265-3274. DOI: 10.2147/CMAR.S191432.
doi: 10.2147/CMAR.S191432 pmid: 31114364 |
[4] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87-108. DOI: 10.3322/caac.21262.
doi: 10.3322/caac.21262 pmid: 25651787 |
[5] |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015,136(5):E359-E386. DOI: 10.1002/ijc.29210.
doi: 10.1002/ijc.29210 pmid: 25220842 |
[6] |
Lou F, Sima CS, Adusumilli PS, et al. Esophageal cancer recurrence patterns and implications for surveillance[J]. J Thorac Oncol, 2013,8(12):1558-1562. DOI: 10.1097/01.JTO.0000437420.38972.fb.
doi: 10.1097/01.JTO.0000437420.38972.fb pmid: 24389438 |
[7] | 刘尚国, 齐博, 赵宝生, 等. 食管癌根治术后早期复发转移的影响因素[J]. 中国老年学杂志, 2016,36(16):3992-3994. DOI: 10.3969/j.issn.1005-9202.2016.16.056. |
[8] |
Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis[J]. Cell, 2006,124(2):263-266. DOI: 10.1016/j.cell.2006.01.007.
doi: 10.1016/j.cell.2006.01.007 pmid: 16439202 |
[9] |
Jain S, Harris J, Ware J. Platelets: linking hemostasis and cancer[J]. Arterioscler Thromb Vasc Biol, 2010,30(12):2362-2367. DOI: 10.1161/ATVBAHA.110.207514.
doi: 10.1161/ATVBAHA.110.207514 pmid: 21071699 |
[10] |
Najafi M, Goradel NH, Farhood B, et al. Tumor microenvironment: interactions and therapy[J]. J Cell Physiol, 2019,234(5):5700-5721. DOI: 10.1002/jcp.27425.
doi: 10.1002/jcp.27425 pmid: 30378106 |
[11] |
Cananzi FCM, Minerva EM, Samà L, et al. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors[J]. J Surg Oncol, 2019,119(1):12-20. DOI: 10.1002/jso.25290.
pmid: 30426498 |
[12] |
Lin JP, Lin JX, Cao LL, et al. Preoperative lymphocyte-to-monocyte ratio as a strong predictor of survival and recurrence for gastric cancer after radical-intent surgery[J]. Oncotarget, 2017,8(45):79234-79247. DOI: 10.18632/oncotarget.17058.
doi: 10.18632/oncotarget.17058 pmid: 29108302 |
[13] |
Guo Y, Chua DW, Koh YX, et al. Preoperative predictors including the role of inflammatory indices in predicting early recurrence after re-resection for recurrent hepatocellular carcinoma[J]. World J Surg, 2019,43(10):2587-2594. DOI: 10.1007/s00268-019-05051-6.
doi: 10.1007/s00268-019-05051-6 pmid: 31222641 |
[14] |
Huang Y, Feng JF. Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma[J]. Onco Targets Ther, 2015,8:137-145. DOI: 10.2147/OTT.S73794.
doi: 10.2147/OTT.S73794 pmid: 25609981 |
[15] |
Hu G, Liu G, Ma JY, et al. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis[J]. Clin Chim Acta, 2018,486:44-48. DOI: 10.1016/j.cca.2018.07.029.
doi: 10.1016/j.cca.2018.07.029 pmid: 30028962 |
[16] |
Sun Y, Zhang L. The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis[J]. Cancer Manag Res, 2018,10:6167-6179. DOI: 10.2147/CMAR.S171035.
doi: 10.2147/CMAR |
[1] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[2] | Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[3] | Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[4] | Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei. Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction [J]. Journal of International Oncology, 2024, 51(4): 193-197. |
[5] | Wan Fang, Yang Gang, Li Rui, Wan Qijing. Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer [J]. Journal of International Oncology, 2024, 51(4): 204-209. |
[6] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[7] | Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying. Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2023, 50(8): 475-483. |
[8] | Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer. Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma (2023 Edition) [J]. Journal of International Oncology, 2023, 50(7): 385-397. |
[9] | Yang Lirong, Wang Yufeng. Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer [J]. Journal of International Oncology, 2023, 50(4): 220-226. |
[10] | Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin. Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma [J]. Journal of International Oncology, 2023, 50(2): 117-121. |
[11] | Ji Shiyu, Zhang Mingxin, Xie Huahong, Bai Yuan, Wang Tong. Observation on the efficacy of different stents in the treatment of patients with advanced esophageal cancer [J]. Journal of International Oncology, 2023, 50(2): 76-81. |
[12] | Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng. Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy [J]. Journal of International Oncology, 2023, 50(12): 745-750. |
[13] | Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou. Advances in immunotherapy for recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2022, 49(9): 517-520. |
[14] | Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei. Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(8): 464-472. |
[15] | Peng Chen, Xie Yintong, Zhang Xin, Xie Peng. Research progress of maintenance therapy for cervical cancer [J]. Journal of International Oncology, 2022, 49(7): 430-435. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||